Literature DB >> 7506726

Expression and function of CD7 molecule on human natural killer cells.

H Rabinowich1, L Pricop, R B Herberman, T L Whiteside.   

Abstract

The CD7 molecule, one of the earliest T-lymphocyte Ag expressed during ontogeny, has recently been demonstrated to facilitate activation of T cells and to preferentially activate TCR-gamma/delta + subset of T cells. The CD7 Ag is also expressed on human NK cells, but its function has not been determined. In this study, expression and function of CD7 Ag on highly enriched NK cells (94 +/- 3% mean +/- SD, n = 12) obtained by negative selection from peripheral blood of normal donors were investigated. The CD7 Ag was found to be expressed at a significantly (p < 0.002) higher level on fresh NK cells than on IL-2-activated, NK cells. CD7 on human NK cells was found to be a signal-transducing molecule with a rapid increase in cytoplasmic free calcium observed on binding of anti-CD7 mAb to the surface of NK cells. Cross-linking of CD7 induced expression of surface activation molecules such as CD25, CD71, HLA-DR, CD69, and CD54. Activation by anti-CD7 mAb cross-linked to plastic or through goat anti-mouse Ig also induced a variety of NK cell functions: it stimulated secretion of IFN-gamma, led to proliferation of NK cells, as measured by [3H]thymidine incorporation, and significantly enhanced cytotoxicity of NK cells against K562 targets (p < 0.03). However, CD7 on NK cells did not seem to transduce a lytic signal, because it neither mediated redirected killing of Fc gamma R+ murine mastocytoma P815 cells nor triggered lysis of a hybridoma expressing the antibody in a membrane-bound form. CD7 molecules appeared to have a regulatory role in adhesion of NK cells to fibronectin, because cross-linking of CD7 on resting NK cells significantly augmented their adhesion to fibronectin-coated plastic surfaces. However, this induced adhesion was not associated with increased expression of beta 1-integrins on NK cells. Thus, CD7-mediated signals appear to augment function of adhesion molecules on NK cells, which may be involved in NK cell activation by providing both anchorage and costimulatory triggering.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506726

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.

Authors:  Andrew M Rogers; Jonathan E Brammer
Journal:  Curr Hematol Malig Rep       Date:  2020-08       Impact factor: 3.952

3.  CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia.

Authors:  Diogo Gomes-Silva; Erden Atilla; Pinar Ataca Atilla; Feiyan Mo; Haruko Tashiro; Madhuwanti Srinivasan; Premal Lulla; Rayne H Rouce; Joaquim M S Cabral; Carlos A Ramos; Malcolm K Brenner; Maksim Mamonkin
Journal:  Mol Ther       Date:  2018-10-04       Impact factor: 11.454

4.  FLT3 and NPM1 mutations in Chinese patients with acute myeloid leukemia and normal cytogenetics.

Authors:  Lei Wang; Wei-lai Xu; Hai-tao Meng; Wen-bin Qian; Wen-yuan Mai; Hong-yan Tong; Li-ping Mao; Yin Tong; Jie-jing Qian; Yin-jun Lou; Zhi-mei Chen; Yun-gui Wang; Jie Jin
Journal:  J Zhejiang Univ Sci B       Date:  2010-10       Impact factor: 3.066

5.  Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.

Authors:  Jeffrey M Milush; Brian R Long; Jennifer E Snyder-Cappione; Amedeo J Cappione; Vanessa A York; Lishomwa C Ndhlovu; Lewis L Lanier; Jakob Michaëlsson; Douglas F Nixon
Journal:  Blood       Date:  2009-10-05       Impact factor: 22.113

6.  CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.

Authors:  Diogo Gomes-Silva; Madhuwanti Srinivasan; Sandhya Sharma; Ciaran M Lee; Dimitrios L Wagner; Timothy H Davis; Rayne H Rouce; Gang Bao; Malcolm K Brenner; Maksim Mamonkin
Journal:  Blood       Date:  2017-05-24       Impact factor: 22.113

Review 7.  Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress.

Authors:  Juanjuan Zhao; Meirong Wu; Zhifeng Li; Sheng Su; Yin Wen; Litian Zhang; Yuhua Li
Journal:  Ann Hematol       Date:  2020-05-09       Impact factor: 3.673

8.  Simian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cells.

Authors:  Qing Wei; Jackie W Stallworth; Patricia J Vance; James A Hoxie; Patricia N Fultz
Journal:  Clin Vaccine Immunol       Date:  2006-07

9.  Expression of the CD7 ligand K-12 in human thymic epithelial cells: regulation by IFN-gamma.

Authors:  Gordon K Lam; Hua-Xin Liao; Yan Xue; S Munir Alam; Richard M Scearce; Russel E Kaufman; Gregory D Sempowski; Barton F Haynes
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

10.  Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry.

Authors:  L Ginaldi; N Farahat; E Matutes; M De Martinis; R Morilla; D Catovsky
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.